Jump to content

Flavivirus

From Wikipedia, the free encyclopedia
(Redirected from Flavivirus DB element)

Flavivirus
A TEM micrograph of the "Yellow fever virus"
A TEM micrograph of Yellow fever virus
"Zika virus" capsid model, colored by chains, PDB entry 5ire
Zika virus viral envelope model, colored by chains, PDB entry 5ire[2]
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Kitrinoviricota
Class: Flasuviricetes
Order: Amarillovirales
Family: Flaviviridae
Genus: Flavivirus
Species[1]

See text

Flavivirus, renamed Orthoflavivirus in 2023,[3] is a genus of positive-strand RNA viruses in the family Flaviviridae. The genus includes the West Nile virus, dengue virus, tick-borne encephalitis virus, yellow fever virus, Zika virus and several other viruses which may cause encephalitis,[4] as well as insect-specific flaviviruses (ISFs) such as cell fusing agent virus (CFAV), Palm Creek virus (PCV), and Parramatta River virus (PaRV).[5] While dual-host flaviviruses can infect vertebrates as well as arthropods, insect-specific flaviviruses are restricted to their competent arthropods.[6] The means by which flaviviruses establish persistent infection in their competent vectors and cause disease in humans depends upon several virus-host interactions, including the intricate interplay between flavivirus-encoded immune antagonists and the host antiviral innate immune effector molecules.[7]

Flaviviruses are named for the yellow fever virus; the word flavus means 'yellow' in Latin, and yellow fever in turn is named from its propensity to cause yellow jaundice in victims.[8]

Flaviviruses share several common aspects: common size (40–65 nm), symmetry (enveloped, icosahedral nucleocapsid), nucleic acid (positive-sense, single-stranded RNA around 10,000–11,000 bases), and appearance under the electron microscope.[citation needed]

Most of these viruses are primarily transmitted by the bite from an infected arthropod (mosquito or tick), and hence are classified as arboviruses. Human infections with most of these arboviruses are incidental, as humans are unable to replicate the virus to high enough titers to reinfect the arthropods needed to continue the virus life-cycle – humans are then a dead end host. The exceptions to this are the yellow fever virus, dengue virus and zika virus. These three viruses still require mosquito vectors but are well-enough adapted to humans as to not necessarily depend upon animal hosts (although they continue to have important animal transmission routes, as well).

Other virus transmission routes for arboviruses include handling infected animal carcasses, blood transfusion, sex, childbirth and consumption of unpasteurised milk products. Transmission from nonhuman vertebrates to humans without an intermediate vector arthropod however mostly occurs with low probability. For example, early tests with yellow fever showed that the disease is not contagious.

The known non-arboviruses of the flavivirus family reproduce in either arthropods or vertebrates, but not both, with one odd member of the genus affecting a nematode.[9]

Structure

[edit]
Zika virus structure and genome

Flaviviruses are enveloped and spherical and have icosahedral geometries with a pseudo T=3 symmetry. The virus particle diameter is around 50 nm.[10]

Genome

[edit]

Flaviviruses have positive-sense, single-stranded RNA genomes which are non-segmented and around 10–11 kbp in length.[10] In general, the genome encodes three structural proteins (Capsid, prM, and Envelope) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5).[11] The genomic RNA is modified at the 5′ end of positive-strand genomic RNA with a cap-1 structure (me7-GpppA-me2).[12]

Life cycle

[edit]
Replication of Japanese encephalitis virus (JEV)

Flaviviruses replicate in the cytoplasm of the host cells. The genome mimics the cellular mRNA molecule in all aspects except for the absence of the poly-adenylated (poly-A) tail. This feature allows the virus to exploit cellular apparatuses to synthesize both structural and non-structural proteins, during replication. The cellular ribosome is crucial to the replication of the flavivirus, as it translates the RNA, in a similar fashion to cellular mRNA, resulting in the synthesis of a single polyprotein.[11]

Cellular RNA cap structures are formed via the action of an RNA triphosphatase, with guanylyltransferase, N7-methyltransferase and 2′-O methyltransferase. The virus encodes these activities in its non-structural proteins. The NS3 protein encodes a RNA triphosphatase within its helicase domain. It uses the helicase ATP hydrolysis site to remove the γ-phosphate from the 5′ end of the RNA. The N-terminal domain of the non-structural protein 5 (NS5) has both the N7-methyltransferase and guanylyltransferase activities necessary for forming mature RNA cap structures. RNA binding affinity is reduced by the presence of ATP or GTP and enhanced by S-adenosyl methionine.[12] This protein also encodes a 2′-O methyltransferase.

Replication complex formed on the cytoplasmic side of the ER membrane

Once translated, the polyprotein is cleaved by a combination of viral and host proteases to release mature polypeptide products.[13] Nevertheless, cellular post-translational modification is dependent on the presence of a poly-A tail; therefore this process is not host-dependent. Instead, the poly-protein contains an autocatalytic feature which automatically releases the first peptide, a virus specific enzyme. This enzyme is then able to cleave the remaining poly-protein into the individual products. One of the products cleaved is a RNA-dependent RNA polymerase, responsible for the synthesis of a negative-sense RNA molecule. Consequently, this molecule acts as the template for the synthesis of the genomic progeny RNA.[citation needed]

Flavivirus genomic RNA replication occurs on rough endoplasmic reticulum membranes in membranous compartments. New viral particles are subsequently assembled. This occurs during the budding process which is also responsible for the accumulation of the envelope and cell lysis.[citation needed]

A G protein-coupled receptor kinase 2 (also known as ADRBK1) appears to be important in entry and replication for several viruses in Flaviviridae.[14]

Humans, mammals, mosquitoes, and ticks serve as the natural host. Transmission routes are zoonosis and bite.[10]

RNA secondary structure elements

[edit]
Flavivirus RNA genome showing the 3' and 5' UTRs and cyclisation

The positive sense RNA genome of Flavivirus contains 5' and 3' untranslated regions (UTRs).

5'UTR

[edit]
Main article: Flavivirus 5' UTR

The 5'UTRs are 95–101 nucleotides long in Dengue virus.[15] There are two conserved structural elements in the Flavivirus 5'UTR, a large stem loop (SLA) and a short stem loop (SLB). SLA folds into a Y-shaped structure with a side stem loop and a small top loop.[15][16] SLA is likely to act as a promoter, and is essential for viral RNA synthesis.[17][18] SLB is involved in interactions between the 5'UTR and 3'UTR which result in the cyclisation of the viral RNA, which is essential for viral replication.[19]

3'UTR

[edit]
Main article: Flavivirus 3' UTR
RNA secondary structure elements of different flavivirus 3′UTRs

The 3'UTRs are typically 0.3–0.5 kb in length and contain a number of highly conserved secondary structures which are conserved and restricted to the flavivirus family. The majority of analysis has been carried out using West Nile virus (WNV) to study the function the 3'UTR.[citation needed]

Currently 8 secondary structures have been identified within the 3'UTR of WNV and are (in the order in which they are found with the 3'UTR) SL-I, SL-II, SL-III, SL-IV, DB1, DB2 and CRE.[20][21] Some of these secondary structures have been characterised and are important in facilitating viral replication and protecting the 3'UTR from 5' endonuclease digestion. Nuclease resistance protects the downstream 3' UTR RNA fragment from degradation and is essential for virus-induced cytopathicity and pathogenicity.[citation needed]

  • SL-II

SL-II has been suggested to contribute to nuclease resistance.[21] It may be related to another hairpin loop identified in the 5'UTR of the Japanese encephalitis virus (JEV) genome.[22] The JEV hairpin is significantly over-represented upon host cell infection and it has been suggested that the hairpin structure may play a role in regulating RNA synthesis.[citation needed]

  • SL-IV

This secondary structure is located within the 3'UTR of the genome of Flavivirus upstream of the DB elements. The function of this conserved structure is unknown but is thought to contribute to ribonuclease resistance.[citation needed]

  • DB1/DB2
Secondary structure of the Flavivirus DB element

These two conserved secondary structures are also known as pseudo-repeat elements. They were originally identified within the genome of Dengue virus and are found adjacent to each other within the 3'UTR. They appear to be widely conserved across the Flaviviradae. These DB elements have a secondary structure consisting of three helices and they play a role in ensuring efficient translation. Deletion of DB1 has a small but significant reduction in translation but deletion of DB2 has little effect. Deleting both DB1 and DB2 reduced translation efficiency of the viral genome to 25%.[20]

  • CRE

CRE is the Cis-acting replication element, also known as the 3'SL RNA elements, and is thought to be essential in viral replication by facilitating the formation of a "replication complex".[23] Although evidence has been presented for an existence of a pseudoknot structure in this RNA, it does not appear to be well conserved across flaviviruses.[24] Deletions of the 3' UTR of flaviviruses have been shown to be lethal for infectious clones.

Conserved hairpin cHP

[edit]

A conserved hairpin (cHP) structure was later found in several Flavivirus genomes and is thought to direct translation of capsid proteins. It is located just downstream of the AUG start codon.[25]

The role of RNA secondary structures in sfRNA production

[edit]
Different fates of viral RNA of flaviviruses and formation of sfRNA

Subgenomic flavivirus RNA (sfRNA) is an extension of the 3' UTR and has been demonstrated to play a role in flavivirus replication and pathogenesis.[26] sfRNA is produced by incomplete degradation of genomic viral RNA by the host cells 5'-3' exoribonuclease 1 (XRN1).[27] As the XRN1 degrades viral RNA, it stalls at stemloops formed by the secondary structure of the 5' and 3' UTR.[28] This pause results in an undigested fragment of genome RNA known as sfRNA. sfRNA influences the life cycle of the flavivirus in a concentration dependent manner. Accumulation of sfRNA causes (1) antagonization of the cell's innate immune response, thus decreasing host defense against the virus[29] (2) inhibition of XRN1 and Dicer activity to modify RNAi pathways that destroy viral RNA[30] (3) modification of the viral replication complex to increase viral reproduction.[31] Overall, sfRNA is implied in multiple pathways that compromise host defenses and promote infection by flaviviruses.[citation needed]

Evolution

[edit]
Phylogenetic tree of Flavivirus with corresponding vectors and groups

The flaviviruses can be divided into two clades: one with vector-borne viruses and the other with no known vector.[32] The vector clade, in turn, can be subdivided into a mosquito-borne clade and a tick-borne clade. These groups can be divided again.[33]

The mosquito group can be divided into two branches: one branch contains neurotropic viruses, often associated with encephalitic disease in humans or livestock. This branch tends to be spread by Culex species and to have bird reservoirs. The second branch is the non-neurotropic viruses associated with human haemorrhagic disease. These tend to have Aedes species as vectors and primate hosts.[citation needed]

The tick-borne viruses also form two distinct groups: one is associated with seabirds and the other – the tick-borne encephalitis complex viruses – is associated primarily with rodents.[citation needed]

The viruses that lack a known vector can be divided into three groups: one closely related to the mosquito-borne viruses, which is associated with bats; a second, genetically more distant, is also associated with bats; and a third group is associated with rodents.[citation needed]

Evolutionary relationships between endogenised viral elements of Flaviviruses and contemporary flaviviruses using maximum likelihood approaches have identified that arthropod-vectored flaviviruses likely emerged from an arachnid source.[34] This contradicts earlier work with a smaller number of extant viruses showing that the tick-borne viruses emerged from a mosquito-borne group.[35]

Several partial and complete genomes of flaviviruses have been found in aquatic invertebrates such as the sea spider Endeis spinosa[36] and several crustaceans and cephalopods.[37] These sequences appear to be related to those in the insect-specific flaviviruses and also the Tamana bat virus groupings. While it is not presently clear how aquatic flaviviruses fit into the evolution of this group of viruses, there is some evidence that one of these viruses, Wenzhou shark flavivirus, infects both a crustacean (Portunus trituberculatus) Pacific spadenose shark (Scoliodon macrorhynchos) shark host,[38][37] indicating an aquatic arbovirus life cycle.

Distribution of major flaviviruses

Estimates of divergence times have been made for several of these viruses.[39] The origin of these viruses appears to be at least 9400 to 14,000 years ago. The Old World and New World dengue strains diverged between 150 and 450 years ago. The European and Far Eastern tick-borne encephalitis strains diverged about 1087 (1610–649) years ago. European tick-borne encephalitis and louping ill viruses diverged about 572 (844–328) years ago. This latter estimate is consistent with historical records. Kunjin virus diverged from West Nile virus approximately 277 (475–137) years ago. This time corresponds to the settlement of Australia from Europe. The Japanese encephalitis group appears to have evolved in Africa 2000–3000 years ago and then spread initially to South East Asia before migrating to the rest of Asia.

Phylogenetic studies of the West Nile virus has shown that it emerged as a distinct virus around 1000 years ago.[40] This initial virus developed into two distinct lineages, lineage 1 and its multiple profiles is the source of the epidemic transmission in Africa and throughout the world. Lineage 2 was considered an Africa zoonosis. However, in 2008, lineage 2, previously only seen in horses in sub-Saharan Africa and Madagascar, began to appear in horses in Europe, where the first known outbreak affected 18 animals in Hungary in 2008.[41] Lineage 1 West Nile virus was detected in South Africa in 2010 in a mare and her aborted fetus; previously, only lineage 2 West Nile virus had been detected in horses and humans in South Africa.[42] A 2007 fatal case in a killer whale in Texas broadened the known host range of West Nile virus to include cetaceans.[43]

Omsk haemorrhagic fever virus appears to have evolved within the last 1000 years.[44] The viral genomes can be divided into 2 clades — A and B. Clade A has five genotypes, and clade B has one. These clades separated about 700 years ago. This separation appears to have occurred in the Kurgan province. Clade A subsequently underwent division into clade C, D and E 230 years ago. Clade C and E appear to have originated in the Novosibirsk and Omsk Provinces, respectively. The muskrat Ondatra zibethicus, which is highly susceptible to this virus, was introduced into this area in the 1930s.

Taxonomy

[edit]

Species

[edit]

In the genus Flavivirus there are 53 defined species:[45]

Sorted by vector

[edit]
List of species and strains of flavivirus by vector


Phylogenetic tree of Flavivirus with vectors; tick-borne (black), mosquito-borne (purple), with no known vector (red), invertebrate viruses (blue/green)

Species and strains sorted by vectors:

Tick-borne viruses

Distribution of tick-borne encephalitis virus (TBEV), Kyasanur forest disease virus (KFDV), Omsk hemorrhagic fever virus (OHFV), Powassan virus (POWV), and Louping-ill virus (LIV)

Mammalian tick-borne virus group

Seabird tick-borne virus group

Mosquito-borne viruses

Viruses with no known arthropod vector

Non vertebrate viruses

Viruses known only from sequencing

Vaccines

[edit]
Time-line of historical highlights of flavivirus research

The very successful yellow fever 17D vaccine, introduced in 1937, produced dramatic reductions in epidemic activity.[citation needed]

Effective inactivated Japanese encephalitis and Tick-borne encephalitis vaccines were introduced in the middle of the 20th century. Unacceptable adverse events have prompted change from a mouse-brain inactivated Japanese encephalitis vaccine to safer and more effective second generation Japanese encephalitis vaccines. These may come into wide use to effectively prevent this severe disease in the huge populations of Asia—North, South and Southeast.[citation needed]

The dengue viruses produce many millions of infections annually due to transmission by a successful global mosquito vector. As mosquito control has failed, several dengue vaccines are in varying stages of development. CYD-TDV, sold under the trade name Dengvaxia, is a tetravalent chimeric vaccine that splices structural genes of the four dengue viruses onto a 17D yellow fever backbone.[50][51] Dengvaxia is approved in five countries.[52]

An alternate approach to the development of flavivirus vaccine vectors is based on the use of viruses that infect insects. Insect-specific flaviviruses, such as Binjari virus, are unable to replicate in vertebrate cells. Nevertheless, recombinant viruses in which structural protein genes (prME) of Binjari virus are exchanged with those of dengue virus, Zika virus, West Nile virus, yellow fever virus, or Japanese encephalitis virus replicate efficiently in insect cells where high titers of infectious virus particles are produced. Immunization of mice with a Binjari vaccine bearing the Zika virus structural proteins protected mice from disease after challenge. A similar approach employs the insect-specific alphavirus Eilat virus as a vaccine platform. ... These new vaccine platforms generated from insect-specific flaviviruses and alphaviruses represent affordable, efficient, and safe approaches to rapid development of infectious, attenuated vaccines against pathogens from these two virus families.[53]

References

[edit]
  1. ^ "Virus Taxonomy: 2018b Release". International Committee on Taxonomy of Viruses (ICTV). March 2019. Retrieved 16 March 2019.
  2. ^ Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG, Kuhn RJ (April 2016). "The 3.8 Å resolution cryo-EM structure of Zika virus". Science. 352 (6284): 467–470. Bibcode:2016Sci...352..467S. doi:10.1126/science.aaf5316. PMC 4845755. PMID 27033547.
  3. ^ Postler TS, Beer M, Blitvich BJ, Bukh J, de Lamballerie X, Drexler JF, Imrie A, Kapoor A, Karganova GG, Lemey P, Lohmann V, Simmonds P, Smith DB, Stapleton JT, Kuhn JH (10 August 2023). "Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae". Archives of Virology. 168 (9): 224. doi:10.1007/s00705-023-05835-1. ISSN 1432-8798. PMID 37561168.
  4. ^ Shi, P-Y, ed. (2012). Molecular Virology and Control of Flaviviruses. Caister Academic Press. ISBN 978-1-904455-92-9.
  5. ^ McLean BJ, Hobson-Peters J, Webb CE, Watterson D, Prow NA, Nguyen HD, Hall-Mendelin S, Warrilow D, Johansen CA, Jansen CC, van den Hurk AF, Beebe NW, Schnettler E, Barnard RT, Hall RA (2015). "A novel insect-specific flavivirus replicates only in Aedes-derived cells and persists at high prevalence in wild Aedes vigilax populations in Sydney, Australia". Virology. 486: 272–283. doi:10.1016/j.virol.2015.07.021. PMID 26519596.
  6. ^ Elrefaey AM, Abdelnabi R, Rosales Rosas AL, Wang L, Basu S, Delang L (September 2020). "Understanding the Mechanisms Underlying Host Restriction of Insect-Specific Viruses". Viruses. 12 (9): 964. doi:10.3390/v12090964. PMC 7552076. PMID 32878245.
  7. ^ Elrefaey AM, Hollinghurst P, Reitmayer CM, Alphey L, Maringer K (November 2021). "Innate Immune Antagonism of Mosquito-Borne Flaviviruses in Humans and Mosquitoes". Viruses. 13 (11): 2116. doi:10.3390/v13112116. PMC 8624719. PMID 34834923.
  8. ^ The earliest mention of "yellow fever" appears in a manuscript of 1744 by John Mitchell of Virginia; copies of the manuscript were sent to Mr. Cadwallader Colden, a physician in New York, and to Benjamin Rush of Philadelphia; the manuscript was eventually reprinted in 1814. See: The term "yellow fever" appears on p. 186. On p. 188, Mitchell mentions "... the distemper was what is generally called the yellow fever in America." However, on pages 191–192, he states "... I shall consider the cause of the yellowness which is so remarkable in this distemper, as to have given it the name of the Yellow Fever." Mitchell misdiagnosed the disease that he observed and treated, and the disease was probably Weil's disease or hepatitis. See: Saul Jarcho (1957) "John Mitchell, Benjamin Rush, and Yellow fever". Bulletin of the History of Medicine, 31 (2): 132–6.
  9. ^ a b Bekal S, Domier LL, Gonfa B, McCoppin NK, Lambert KN, Bhalerao K (2014). "A novel flavivirus in the soybean cyst nematode". Journal of General Virology. 95 (Pt 6): 1272–1280. doi:10.1099/vir.0.060889-0. PMID 24643877.
  10. ^ a b c "Viral Zone". ExPASy. Archived from the original on 17 June 2015. Retrieved 15 June 2015.
  11. ^ a b Rice C, Lenches E, Eddy S, Shin S, Sheets R, Strauss J (23 August 1985). "Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution". Science. 229 (4715): 726–33. Bibcode:1985Sci...229..726R. doi:10.1126/science.4023707. PMID 4023707. Retrieved 14 November 2016.
  12. ^ a b Henderson BR, Saeedi BJ, Campagnola G, Geiss BJ (2011). Jeang K (ed.). "Analysis of RNA binding by the Dengue virus NS5 RNA capping enzyme". PLOS ONE. 6 (10): e25795. Bibcode:2011PLoSO...625795H. doi:10.1371/journal.pone.0025795. PMC 3192115. PMID 22022449.
  13. ^ Sun G, Larsen C, Baumgarth N, Klem E, Scheuermann R (26 January 2017). "Comprehensive Annotation of Mature Peptides and Genotypes for Zika Virus". PLOS ONE. 12 (1): e0170462. Bibcode:2017PLoSO..1270462S. doi:10.1371/journal.pone.0170462. PMC 5268401. PMID 28125631.
  14. ^ Le Sommer C, Barrows NJ, Bradrick SS, Pearson JL, Garcia-Blanco MA (2012). Michael SF (ed.). "G protein-coupled receptor kinase 2 promotes flaviviridae entry and replication". PLOS Negl Trop Dis. 6 (9): e1820. doi:10.1371/journal.pntd.0001820. PMC 3441407. PMID 23029581.
  15. ^ a b Gebhard LG, Filomatori CV, Gamarnik AV (2011). "Functional RNA elements in the dengue virus genome". Viruses. 3 (9): 1739–56. doi:10.3390/v3091739. PMC 3187688. PMID 21994804.
  16. ^ Brinton MA, Dispoto JH (1988). "Sequence and secondary structure analysis of the 5'-terminal region of flavivirus genome RNA". Virology. 162 (2): 290–9. doi:10.1016/0042-6822(88)90468-0. PMID 2829420.
  17. ^ Filomatori CV, Lodeiro MF, Alvarez DE, Samsa MM, Pietrasanta L, Gamarnik AV (2006). "A 5' RNA element promotes dengue virus RNA synthesis on a circular genome". Genes Dev. 20 (16): 2238–49. doi:10.1101/gad.1444206. PMC 1553207. PMID 16882970.
  18. ^ Yu L, Nomaguchi M, Padmanabhan R, Markoff L (2008). "Specific requirements for elements of the 5' and 3' terminal regions in flavivirus RNA synthesis and viral replication". Virology. 374 (1): 170–85. doi:10.1016/j.virol.2007.12.035. PMC 3368002. PMID 18234265.
  19. ^ Alvarez DE, Lodeiro MF, Ludueña SJ, Pietrasanta LI, Gamarnik AV (2005). "Long-range RNA-RNA interactions circularize the dengue virus genome". J Virol. 79 (11): 6631–43. doi:10.1128/JVI.79.11.6631-6643.2005. PMC 1112138. PMID 15890901.
  20. ^ a b Chiu WW, Kinney RM, Dreher TW (July 2005). "Control of Translation by the 5′- and 3′-Terminal Regions of the Dengue Virus Genome". J. Virol. 79 (13): 8303–15. doi:10.1128/JVI.79.13.8303-8315.2005. PMC 1143759. PMID 15956576.
  21. ^ a b Pijlman GP, Funk A, Kondratieva N, et al. (December 2008). "A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity". Cell Host Microbe. 4 (6): 579–91. doi:10.1016/j.chom.2008.10.007. PMID 19064258.
  22. ^ Lin KC, Chang HL, Chang RY (May 2004). "Accumulation of a 3′-Terminal Genome Fragment in Japanese Encephalitis Virus-Infected Mammalian and Mosquito Cells". J. Virol. 78 (10): 5133–8. doi:10.1128/JVI.78.10.5133-5138.2004. PMC 400339. PMID 15113895.
  23. ^ Zeng L, Falgout B, Markoff L (September 1998). "Identification of Specific Nucleotide Sequences within the Conserved 3′-SL in the Dengue Type 2 Virus Genome Required for Replication". J. Virol. 72 (9): 7510–22. doi:10.1128/JVI.72.9.7510-7522.1998. PMC 109990. PMID 9696848.
  24. ^ Shi PY, Brinton MA, Veal JM, Zhong YY, Wilson WD (April 1996). "Evidence for the existence of a pseudoknot structure at the 3' terminus of the flavivirus genomic RNA". Biochemistry. 35 (13): 4222–30. doi:10.1021/bi952398v. PMID 8672458.
  25. ^ Clyde K, Harris E (2006). "RNA Secondary Structure in the Coding Region of Dengue Virus Type 2 Directs Translation Start Codon Selection and Is Required for Viral Replication". J Virol. 80 (5): 2170–2182. doi:10.1128/JVI.80.5.2170-2182.2006. PMC 1395379. PMID 16474125.
  26. ^ Bidet K, Garcia-Blanco MA (1 September 2014). "Flaviviral RNAs: weapons and targets in the war between virus and host". Biochemical Journal. 462 (2): 215–230. doi:10.1042/BJ20140456. ISSN 0264-6021. PMID 25102029.
  27. ^ Chapman EG, Costantino DA, Rabe JL, Moon SL, Wilusz J, Nix JC, Kieft JS (18 April 2014). "The Structural Basis of Pathogenic Subgenomic Flavivirus RNA (sfRNA) Production". Science. 344 (6181): 307–310. Bibcode:2014Sci...344..307C. doi:10.1126/science.1250897. ISSN 0036-8075. PMC 4163914. PMID 24744377.
  28. ^ Funk A, Truong K, Nagasaki T, Torres S, Floden N, Melian EB, Edmonds J, Dong H, Shi PY (1 November 2010). "RNA Structures Required for Production of Subgenomic Flavivirus RNA". Journal of Virology. 84 (21): 11407–11417. doi:10.1128/JVI.01159-10. ISSN 0022-538X. PMC 2953152. PMID 20719943.
  29. ^ Chang RY, Hsu TW, Chen YL, Liu SF, Tsai YJ, Lin YT, Chen YS, Fan YH (27 September 2013). "Japanese encephalitis virus non-coding RNA inhibits activation of interferon by blocking nuclear translocation of interferon regulatory factor 3". Veterinary Microbiology. 166 (1–2): 11–21. doi:10.1016/j.vetmic.2013.04.026. PMID 23755934.
  30. ^ Moon SL, Anderson JR, Kumagai Y, Wilusz CJ, Akira S, Khromykh AA, Wilusz J (1 November 2012). "A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability". RNA. 18 (11): 2029–2040. doi:10.1261/rna.034330.112. ISSN 1355-8382. PMC 3479393. PMID 23006624.
  31. ^ Clarke BD, Roby JA, Slonchak A, Khromykh AA (3 August 2015). "Functional non-coding RNAs derived from the flavivirus 3′ untranslated region". Virus Research. Special Issue: Functions of the ends of positive strand RNA virus genomes. 206: 53–61. doi:10.1016/j.virusres.2015.01.026. PMID 25660582.
  32. ^ Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB (1998). "Phylogeny of the genus Flavivirus". J Virol. 72 (1): 73–83. doi:10.1128/JVI.72.1.73-83.1998. PMC 109351. PMID 9420202.
  33. ^ Gaunt MW, Sall AA, de Lamballerie X, Falconar AK, Dzhivanian TI, Gould EA (2001). "Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography". J Gen Virol. 82 (8): 1867–1876. doi:10.1099/0022-1317-82-8-1867. PMID 11457992.
  34. ^ Bamford CGG, de Souza WM, Parry R, Gifford RJ (2022). "Comparative analysis of genome-encoded viral sequences reveals the evolutionary history of flavivirids (family Flaviviridae)". Virus Evol. 8 (2): veac085. doi:10.1093/ve/veac085. PMC 9752770. PMID 36533146.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  35. ^ Cook S, Holmes EC (2006). "A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission". Arch Virol. 151 (2): 309–325. doi:10.1007/s00705-005-0626-6. PMID 16172840.
  36. ^ Conway MJ (2015). "Identification of a flavivirus sequence in a marine arthropod". PLOS ONE. 10 (12): e0146037. Bibcode:2015PLoSO..1046037C. doi:10.1371/journal.pone.0146037. PMC 4699914. PMID 26717191.
  37. ^ a b Parry R, Asgari S (2019). "Discovery of Novel Crustacean and Cephalopod Flaviviruses: Insights into the Evolution and Circulation of Flaviviruses between Marine Invertebrate and Vertebrate Hosts". J Virol. 93 (14). doi:10.1128/JVI.00432-19. PMC 6600200. PMID 31068424.
  38. ^ Shi M, Lin XD, Chen X, Tian JH, Chen LJ, Li K, et al. (2018). "The evolutionary history of vertebrate RNA viruses". Nature. 556 (7700): 197–202. Bibcode:2018Natur.556..197S. doi:10.1038/s41586-018-0012-7. PMID 29618816. S2CID 256771319.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  39. ^ Moureau G, Cook S, Lemey P, Nougairede A, Forrester NL, Khasnatinov M, Charrel RN, Firth AE, Gould EA, De Lamballerie X (2015). "New Insights into Flavivirus Evolution, Taxonomy and Biogeographic History, Extended by Analysis of Canonical and Alternative Coding Sequences". PLOS ONE. 10 (2): e0117849. Bibcode:2015PLoSO..1017849M. doi:10.1371/journal.pone.0117849. PMC 4342338. PMID 25719412.
  40. ^ Galli M, Bernini F, Zehender G (July 2004). "Alexander the Great and West Nile virus encephalitis". Emerging Infect. Dis. 10 (7): 1330–2, author reply 1332–3. doi:10.3201/eid1007.040396. PMID 15338540.
  41. ^ West, Christy (8 February 2010). "Different West Nile Virus Genetic Lineage Evolving?". The Horse. Retrieved 10 February 2010. From statements by Orsolya Kutasi, DVM, of the Szent Istvan University, Hungary at the 2009 American Association of Equine Practitioners Convention, December 5–9, 2009.
  42. ^ Venter M, Human S, van Niekerk S, Williams J, van Eeden C, Freeman F (August 2011). "Fatal neurologic disease and abortion in mare infected with lineage 1 West Nile virus, South Africa". Emerging Infect. Dis. 17 (8): 1534–6. doi:10.3201/eid1708.101794. PMC 3381566. PMID 21801644.
  43. ^ St Leger J, Wu G, Anderson M, Dalton L, Nilson E, Wang D (2011). "West Nile virus infection in a killer whale, Texas, USA, 2007". Emerging Infect. Dis. 17 (8): 1531–3. doi:10.3201/eid1708.101979. PMC 3381582. PMID 21801643.
  44. ^ Karan LS, Ciccozzi M, Yakimenko VV, Presti AL, Cella E, Zehender G, Rezza G, Platonov AE (2014). "The deduced evolution history of Omsk hemorrhagic fever virus". Journal of Medical Virology. 86 (7): 1181–1187. doi:10.1002/jmv.23856. PMID 24259273. S2CID 36929638.
  45. ^ "International Committee on Taxonomy of Viruses (ICTV)". talk.ictvonline.org. Retrieved 16 November 2020.
  46. ^ Robin Y, Cornet M, Le Gonidec G, Chateau R, Heme G (1978). "[Kedougou virus (Ar D14701): a new Arbovirus ("Flavivirus") isolated in Senegal (author's transl)]". Ann Microbiol (Paris). 129 (2): 239–44. PMID 677616.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  47. ^ Jansen van Vuren P, Parry R, Khromykh AA, Paweska JT (2021). "A 1958 Isolate of Kedougou Virus (KEDV) from Ndumu, South Africa, Expands the Geographic and Temporal Range of KEDV in Africa". Viruses. 13 (7): 1368. doi:10.3390/v13071368. PMC 8309962. PMID 34372574.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  48. ^ van den Hurk AF, Suen WW, Hall RA, O'Brien CA, Bielefeldt-Ohmann H, Hobson-Peters J, Colmant AM (2016). "A newly discovered flavivirus in the yellow fever virus group displays restricted replication in vertebrates". Journal of General Virology. 97 (5): 1087–1093. doi:10.1099/jgv.0.000430. PMID 26878841. S2CID 43127614.
  49. ^ a b c d e Parry R, Asgari S (15 July 2019). "Discovery of Novel Crustacean and Cephalopod Flaviviruses: Insights into the Evolution and Circulation of Flaviviruses between Marine Invertebrate and Vertebrate Hosts". Journal of Virology. 93 (14). doi:10.1128/JVI.00432-19. PMC 6600200. PMID 31068424.
  50. ^ Thisyakorn U (2014). "Latest developments and future directions in dengue vaccines". Therapeutic Advances in Vaccines. 2 (1): 3–9. doi:10.1177/2051013613507862. PMC 3991153. PMID 24757522.
  51. ^ Yauch LE (2014). Dengue Virus Vaccine Development. Advances in Virus Research. Vol. 88. pp. 315–372. doi:10.1016/B978-0-12-800098-4.00007-6. ISBN 978-0-12-800098-4. PMID 24373316.
  52. ^ "WHO Questions and Answers on Dengue Vaccines". WHO.int. Retrieved 1 October 2016.
  53. ^ Flint J, Racaniello VR, Rall GF, Hatziiannou T, Skalka AM (3 August 2020). Principles of Virology, Volume 2: Pathogenesis and Control (5th ed.). John Wiley & Sons. p. 327. ISBN 978-1-68367-283-8.

Further reading

[edit]
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Flavivirus&oldid=1218650249"